These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7771496)

  • 1. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade.
    Stewart RJ; Marsden PA
    Am J Kidney Dis; 1995 Jun; 25(6):954-66. PubMed ID: 7771496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    Carlson NG; Wieggel WA; Chen J; Bacchi A; Rogers SW; Gahring LC
    J Immunol; 1999 Oct; 163(7):3963-8. PubMed ID: 10490998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine networks in destructive periodontal disease.
    Howells GL
    Oral Dis; 1995 Dec; 1(4):266-70. PubMed ID: 8705835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Chest; 1997 Dec; 112(6 Suppl):321S-329S. PubMed ID: 9400897
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokines and anticytokines in the pathogenesis of sepsis.
    van der Poll T; van Deventer SJ
    Infect Dis Clin North Am; 1999 Jun; 13(2):413-26, ix. PubMed ID: 10340175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytokines and anti-cytokines in inflammatory rheumatism].
    Dayer JM
    Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):173S-180S. PubMed ID: 7858569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-8, and interleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction.
    Imamura S; Matsukawa A; Ohkawara S; Kagayama M; Yoshinaga M
    Pathol Int; 1997 Jan; 47(1):16-24. PubMed ID: 9051688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1.
    Dinarello CA
    Cytokine Growth Factor Rev; 1997 Dec; 8(4):253-65. PubMed ID: 9620641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells.
    Jobin C; Holt L; Bradham CA; Streetz K; Brenner DA; Sartor RB
    J Immunol; 1999 Apr; 162(8):4447-54. PubMed ID: 10201981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB; Shopp GM
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):397-419. PubMed ID: 8872492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
    Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors.
    Hattar K; Fink L; Fietzner K; Himmel B; Grimminger F; Seeger W; Sibelius U
    J Immunol; 2001 May; 166(10):6287-93. PubMed ID: 11342652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin.
    Barr RM; Walker SL; Tsang W; Harrison GI; Ettehadi P; Greaves MW; Young AR
    J Invest Dermatol; 1999 May; 112(5):692-8. PubMed ID: 10233758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome.
    Dinarello CA; Gelfand JA; Wolff SM
    JAMA; 1993 Apr; 269(14):1829-35. PubMed ID: 8459516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respective effects of soluble interleukin-1 receptor and tumour necrosis factor receptor on IL-1 and TNF-alpha-induced DNA synthesis of common acute lymphoblastic leukaemia blasts in vitro.
    Carter A; Haddad N; Draxler I; Israeli E; Raz B; Tatarsky I
    Br J Haematol; 1994 Jan; 86(1):22-9. PubMed ID: 8011537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of tumor necrosis factor-alpha in keratinocytes mediated by interleukin-1beta and tumor necrosis factor-alpha.
    Lisby S; Hauser C
    Exp Dermatol; 2002 Dec; 11(6):592-8. PubMed ID: 12473067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
    Dinarello CA
    Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.